Pay in 4 interest-free payments of $6.62 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
tirzepatide is a dual GIP/GLP-1 incretin agonist
FDAs Pharmaceutical Compounding Advisory Committee voted to add six of seven peptides to the 503A Bulk Drug Substance List, despite FDA scientists recommending against all of them because of limited evidence of their safety and effectiveness
The compound is commonly used in metabolic research exploring mechanisms of appetite signaling, insulin pathway modulation, and cellular energy regulation
I usually recommend stirring a spoonful into oatmeal, yogurt, coffee, or a smoothie
US$ 20.84
US$ 21.17
US$ 27.71
US$ 24.72
